DIN/PIN Detail - 02258102

920000   MISCELLANEOUS THERAPEUTIC AGENTS

ACT ALENDRONATE 40 MG ORAL TABLET

(ALENDRONATE SODIUM)

Manufacturer:
ACTAVIS PHARMA COMPANY
ECDET Review Status/Past Decision(s):

 2012/12/01 - Special Authorization Criteria Change


 2009/07/01 - Special Authorization Criteria Change


 2006/04/01 - Special Authorization Criteria Change


 2006/01/01 - Special Authorization

CDR Status/Past Decision(s):
N/A

To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.